Red Yeast Rice by Doctor’s Best: Recall - Undeclared Lovastatin
Audience: Consumer
ISSUE: Doctor’s Best is voluntarily recalling lot 3121005 (7379 bottles) of Red Yeast Rice dietary supplement, 600 mg Capsules, 120-count bottles to the retail level. Doctor’s Best Red Yeast Rice has been found to contain undeclared lovastatin, a previously approved drug indicated for the treatment of high cholesterol, making this an unapproved new drug.
Consumers who use supplements found to contain lovastatin in rare cases could result in serious muscle injury; particularly if taking with prescription “statins” such as lovastatin, simvastatin, or atorvastatin. Pregnant women could theoretically put their unborn child at risk by using this product with undeclared lovastatin. Patients with pre-existing liver disease may be at an increase risk for liver injury following chronic use of statins.
BACKGROUND: Doctor’s Best Red Yeast Rice was distributed nationwide through retail and internet outlets. Doctor’s Best Red Yeast Rice is marketed as a dietary supplement for lowering cholesterol and is packaged in white plastic bottle with orange flip-top lid, and clear tamper evident outer seal number of units, UPC code 753950001183. Lot 3121005 and expires February 2017.
RECOMMENDATION: Doctor’s Best is notifying its distributors and customers by mail and is arranging for return of all recalled products. Consumers/distributors/retailers that have Red Yeast Rice which is being recalled should discontinue usage and return the unused portion to their place of purchase.
Consumers with questions regarding this recall can contact Doctor’s Best at 1-844-717-0190 Monday through Friday 9am to 5pm PDT and contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.
[06/24/2014 - Press Release - Doctor’s Best]
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.